BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8057741)

  • 1. [Post-vaccination measles immunity in children on long-term anticonvulsant therapy].
    Popović-Miocinović L; Smerdel S; Grubesić Z; Miklousić A
    Lijec Vjesn; 1994; 116(3-4):74-8. PubMed ID: 8057741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of antibody titres after measles vaccination: fever within 7 days of vaccination and efficacy of booster doses.
    Egami T; Egami K; Tanoue A
    Arch Dis Child; 2008 Apr; 93(4):319-20. PubMed ID: 17488762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of immunity against measles in persons immunized with Edmonston-Zagreb vaccine.
    abu Eldan J; Borćić B; Smerdel S
    Acta Med Croatica; 1991; 45(4-5):297-304. PubMed ID: 1726513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to measles immunization and the impacts on HIV-infected children.
    Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Loss of maternal measles antibodies acquired by vaccination against measles].
    Strauss J; Mrázová M; Macátová I; Beranová I
    Cesk Epidemiol Mikrobiol Imunol; 1991 May; 40(3):137-43. PubMed ID: 1828716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
    Oyefolu AO; Omilabu SA
    West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of three measles vaccines in Indian children.
    Banerjee K; Shaikh N; Phadke M; Bedekar SS; Rauta SK; Mehta JM
    Indian J Public Health; 1998; 42(4):113-9. PubMed ID: 10389523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.